Background: Distinguishing between stroke subtypes and knowing the time of stroke onset
are critical in clinical practice. Thrombolysis and thrombectomy are very effective treatments …

Biomarkers are objective indicators used to assess normal or pathological processes,
evaluate responses to treatment and predict outcomes. Many blood biomarkers already …

Background Preclinical data suggest circadian variation in ischemic stroke progression, with
more active cell death and infarct growth in rodent models with inactive phase (daytime) …

Background The objective of this study was to determine whether:(a) markers of acute
inflammation (white cell count, glucose, interleukin-6, C-reactive protein, and fibrinogen) are …

This review provides a summary of the protein and RNA biomarkers that have been studied
for the diagnosis and assessment of ischemic stroke. Many of the biomarkers identified …

Lacunar stroke is generally considered to have a fair outcome. However 20–30% of patients
with lacunar stroke worsen neurologically in hours or days after onset, reaching eventually …

Biomarkers are measurable substances that could be used as objective indicators for
disease diagnosis, responses to treatments, and outcomes predictions. In this review, we …

Stroke represents one of the most important causes of disability and death in developed
countries. However, there is a lack of prognostic tools in clinical practice to monitor the …

Glia form a central component of the nervous system whose varied activities sustain an
environment that is optimised for healthy development and neuronal function. Alpha-amino …

Ischemic stroke is a serious public health problem worldwide. Here, we characterized the
metabolite features of acute ischemic stroke (AIS) using a gas chromatography-mass …